We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

67 hedge funds and large institutions have $144M invested in OptiNose in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

5% more funds holding

Funds holding: 6467 (+3)

0.44% more ownership

Funds ownership: 3.35%3.8% (+0.44%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

44% less capital invested

Capital invested by funds: $258M → $144M (-$113M)

Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
1.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
26
Reduced
14
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MIM
76
MetLife Investment Management
New Jersey
-$101K -542 Closed
MLICM
77
Metropolitan Life Insurance Company (MetLife)
New York
-$71.4K -383 Closed
PHK
78
Point72 Hong Kong
Hong Kong
-$14K -75 Closed
LTFS
79
Ladenburg Thalmann Financial Services
Florida
+$286 +2 New

OPTN Hedge Fund Activity: Q4 2018 in Review

67 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q4 2018, worth a combined $144M — down 44% from $258M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new OPTN positions and 13 closed out — a net gain of 4 holders — while 26 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $7.08M. The largest seller was Tamarack Advisers, cutting an estimated $5.33M.

  • 67 institutional investors held OptiNose (OPTN) as of Q4 2018, up from 64 in Q3 2018.
  • Funds reported $144M of OptiNose stock for Q4 2018, down 44% quarter-over-quarter.
  • 17 funds opened new OptiNose positions in Q4 2018 and 13 closed out, a net change of +4 holders.
  • The largest OptiNose buyer in Q4 2018 was BlackRock, an estimated $7.08M added.
  • The largest OptiNose seller in Q4 2018 was Tamarack Advisers, an estimated $5.33M sold.

Based on aggregated 13F filings for Q4 2018.